Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 31

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 31
---
 Combination within the completion window. •In connection with a special meeting of NorthView stockholders, held on March10, 2023, the NorthView stockholders elected to redeem 18,000,868 public shares of NorthView Common Stock related to the extension of NorthView’s business combination period monthly, for up to nine months, from March22, 2023, ultimately until as late as December22, 2023. Separately, the NorthView stockholders previously elected to redeem 140,663 public shares of NorthView Common Stock in connection with a shareholder meeting on December21, 2023, related to the extension of NorthView’s business combination period monthly, for up to three months, from December22, 2023, ultimately until as late as March22, 2024. Additionally, the NorthView stockholders elected to redeem 95,394 public shares of NorthView Common Stock in connection with a shareholder meeting on March21, 2024, related to the extension of NorthView’s business combination period monthly, for up to six months, from March22, 2024, ultimately until as late as September22, 2024. On September19, 2024, the NorthView stockholders elected to redeem 50,556 public shares of NorthView Common Stock in connection with the extension of NorthView’s business combination period monthly, for up to six months, from September22, 2024, ultimately until as late as March22, 2025. On March21, 2025, the NorthView stockholders elected to redeem 532,958 public shares of NorthView Common Stock in connection with the extension of NorthView’s business combination period from March22, 2025, until June22, 2025. At the time of the stockholder vote on March21, 2025, NorthView’s stockholders redeemed 9.1% of the total outstanding shares. The aggregate of 18,820,439 public shares redeemed in connection with the Extension represented approximately 77.9% of the total NorthView shares of common stock outstanding following NorthView’s IPO and approximately 99.2% of the public shares previously outstanding. As of March21, 2025, NorthView had 154,561 public shares of NorthView Common Stock outstanding, and held approximately $1.9 million in the Trust Account. x •Profusa, Inc., a California corporation, which we refer to as “Profusa”, is a digital health technology company based in